Asimov is listed by Robinhood as a YCW26 company in the Robinhood Ventures Fund II portfolio. Robinhood reports the fund's exposure may be direct or through one or more SPVs.
Technology
Current Valuation
Private
PRIVATE
QL Price
$1.0B
0% vs last round
QuantLogix's current estimate for Asimov, published 2026-11-10 — in line with the last disclosed round of $1.0B (2026-02).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$1.0B
2026-02
weight 0.59
How this price has held up
No round has priced for Asimov since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-11-10 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Asimov, 2026-11-10 (60070b06b6ec97d2).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Asimov going public?
No. Asimov is private and has not filed to go public. There is no S-1 on file.
What is Asimov's valuation in 2026?
No confirmed valuation is on record for Asimov. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Asimov filed an S-1?
No public S-1 is on file for Asimov.
Is Asimov publicly traded — can you buy Asimov stock?
No. Asimov is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Asimov on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
IPO Status
private
Fundraising Status
Company-specific financing undisclosed — Robinhood’s RVII portfolio disclosure reports fund exposure, not a company financing amount, round, or date. YC standard program backing is separately attributed below.
private
Talent Signal
Hiring trend
▲ Hiring uptrend
+50% vs 2026-09
Open roles
6
via ashby
Product-build share
100%
engineering, research, product, design
Trajectory
scaling
heavy product build — 100% of open roles are product-building functions (engineering/research/product) — 5 of 6 open roles are research.
Executive bench growing while hiring expands: 1 senior hire (CEO); open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Key Executive Moves
INKatie SteinCEO · 2026-09-03
From trusted-source news extraction (deep-enrich pipeline); dates approximate publication, not effective date.
Senior Scientist, Biologics Cell Line DevelopmentPrincipal Scientist, Biologics Cell Line DevelopmentSenior Program ManagerSenior Scientist, Lentiviral Vector Cell Line DevelopmentSenior Scientist, Analytical DevelopmentScientist, Lentiviral Vector Cell Line Development
Counted from Asimov's live job board as of 2026-10-14; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Y CombinatorYCW26Robinhood Ventures Fund II
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.